Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Journal of Medicine and Life|October 28, 2017
T cell leukemia control via Ras-Raf pathway inhibition with peptidesG H Marin, A Rebollo, H Bruzzoni-Giovanelli, et al.Journal of Medicine and Life|April 27, 2018
Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptidesG H Marin, A Rebollo, H Bruzzoni-Giovanelli, et al.Boletin De La Asociacion Medica De Puerto Rico|July 1, 1997
Profile of a population using a primary health care center in Puerto RicoM R Moscoso, R A Suarez, M Vélez, et al.European Urology|January 1, 1987
Rokitansky's syndrome in association with reno-ureteral abnormalities. Teratogenic periodJ C Ramirez, A J Puerta, A Rebollo, et al.Leukemia|November 19, 2013
Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cellsR Montes, V Ayllón, C Prieto, et al.The Ceylon Medical Journal|August 29, 2019
New forms of induction of apoptosis in aggressive lymphoma using peptides that interrupt the RAS / RAF interactionC Bergna, G H Marin, M Maiz, et al.Leukemia|March 18, 2015
The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fateV Ayllón, C Bueno, V Ramos-Mejía, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptorsE Fernández-Ruiz, A Rebollo, M A Nieto, et al.Applied Optics|April 9, 2002
Speckle size of light scattered from slightly rough cylindrical surfacesRicardo G Berlasso, Fernando Perez Quintián, María A Rebollo, et al.Revista Espanola De Medicina Nuclear|September 11, 1999
[CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis]J Vallejo, M Torres-Avisbal, P Contreras, et al.Pageof 8